None listed
Conditions
Interventions
Medical Device, Procedure/Surgery : 1. Ultrasound-guided Acupotomy therapy
2. Conventional Physical Therapy (ICT + MW)
Intervention phase : Each group will receive the assigned treatment twice a wee
Sponsors
Pusan National University Korean Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) aged 30 years and older but younger than 75 years 2) pain or discomfort (numbness, paresthesia, muscle weakness) in the cervical spine and upper extremities = VAS 30mm 3) Symptom duration of 3 months or more 4) confirmed to have intervertebral disc herniation, stenosis, or spondylosis on imaging examination (C-spine MRI) - If no previous imaging data are available or re-imaging is required, a cervical spine MRI examination will be performed. 5) Individuals who have received a final diagnosis of degenerative cervical radiculopathy based on comprehensive physical examination, medical history, and imaging examination results 6) Individuals who voluntarily decide to participate after being informed of the study purpose and procedure and provide written informed consent
Exclusion criteria
Exclusion criteria: 1) History or current signs of myelopathy 2) Other spinal diseases or other medical conditions (e.g., thoracic outlet syndrome, carpal tunnel syndrome, plexopathy) that could cause similar symptoms to radiculopathy 3) History of cervical spine surgery or planned surgery during the study period 4) Serious medical history of cervical spine fracture, luxation, tumor, congenital abnormality 5) Infectious or non-infectious spondylitis (e.g., ankylosing spondylitis, rheumatoid arthritis) 6) Individuals deemed unsuitable for the acupotomy procedure due to abnormal hemostasis, such as those taking anticoagulants or antiplatelet drugs, or those with bleeding disorders 7) History of receiving epidural injections, nerve blocks, or other injections within 2 months 8) Individuals with acupuncture hypersensitivity, metal allergies, severe atopic dermatitis, keloid skin, or other skin hypersensitivity 9) Individuals with significant neuropsychiatric medical history or current illness 10) Individuals with a history of alcoholism or drug abuse 11) Pregnant or lactating women or those planning to become pregnant 12) Individuals who are unable to self-report consent/data or require assistance from a caregiver/researcher to do so 13) Other individuals deemed inappropriate by the clinical research coordinator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale (VAS), Cervical and upper extremities pain/discomfort | — |
Secondary
| Measure | Time frame |
|---|---|
| painDETECT;Neck Disability Index (NDI);Depression Anxiety Stress Scale-21 (DASS-21);EuroQol-5D-5L index(EQ-5D-5L) ;SWE (tissue stiffness and elasticity);Patient Global Impression of change (PGIC);Clinically important difference (CID);Use of rescue medication;Safety assessment (Adverse effect);Economic Evaluation | — |
Countries
Korea, Republic of
Contacts
Public ContactEunseok Kim
Pusan National University Korean Medicine Hospital
Outcome results
None listed